INSPIROGENE Trademark

Trademark Overview


On Wednesday, July 31, 2024, a trademark application was filed for INSPIROGENE with the United States Patent and Trademark Office. The USPTO has given the INSPIROGENE trademark a serial number of 98676115. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, February 19, 2025. This trademark is owned by McKesson Plasma and Biologics LLC. The INSPIROGENE trademark is filed in the Advertising, Business and Retail Services and Education & Entertainment Services categories with the following description:

Educational services, namely, conducting seminars and programs in the field of cell and gene therapies and related topics and the distribution of educational and training material in connection therewith

Business services provided across the healthcare industry relating to product distribution, logistics, and supply chain in the field of cell and gene therapies; business advisory and consulting services provided across the healthcare industry relating to research and development of targeted therapies and diagnostics, clinical solutions, patient access, and technology products and services in the field of cell and gene therapies; providing public policy information in the field of cell and gene therapies
inspirogene

General Information


Serial Number98676115
Word MarkINSPIROGENE
Filing DateWednesday, July 31, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, February 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesEducational services, namely, conducting seminars and programs in the field of cell and gene therapies and related topics and the distribution of educational and training material in connection therewith
Pseudo MarkINSPIRO GENE
Goods and ServicesBusiness services provided across the healthcare industry relating to product distribution, logistics, and supply chain in the field of cell and gene therapies; business advisory and consulting services provided across the healthcare industry relating to research and development of targeted therapies and diagnostics, clinical solutions, patient access, and technology products and services in the field of cell and gene therapies; providing public policy information in the field of cell and gene therapies

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2024
Primary Code035
First Use Anywhere DateTuesday, October 1, 2024
First Use In Commerce DateTuesday, October 1, 2024

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2024
Primary Code041
First Use Anywhere DateTuesday, October 1, 2024
First Use In Commerce DateTuesday, October 1, 2024

Trademark Owner History


Party NameMcKesson Plasma and Biologics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIrving, TX 75039

Trademark Events


Event DateEvent Description
Wednesday, July 31, 2024NEW APPLICATION ENTERED
Sunday, February 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 17, 2025TEAS AMENDMENT OF USE RECEIVED
Monday, February 17, 2025AMENDMENT TO USE PROCESSING COMPLETE
Monday, February 17, 2025USE AMENDMENT FILED
Tuesday, February 18, 2025ASSIGNED TO EXAMINER
Wednesday, February 19, 2025NON-FINAL ACTION WRITTEN
Wednesday, February 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 19, 2025NON-FINAL ACTION E-MAILED
Wednesday, February 19, 2025USE AMENDMENT ACCEPTED